Response to influenza vaccine in people with non-protective HI antibody titers
The purpose of the study was to determine which factors correlate directly with response to vaccination in such a group of subjects with non-protective HI antibody titers before vaccination. Two vaccines were used, a subunit virus vaccine adjuvanted with MF59 and a split virus vaccine. The analysis indicated that immunization with vaccine adjuvanted with MF59 was an independent variable for immune response against A/H3N2 (OR: 3.51; 95% CI: 1.81–6.79) and B (OR: 2.31; 95% CI: 1.37–3.89). The results suggest that antibody response to vaccine is satisfactory in elderly people previously lacking a protective antibody titer, and that the adjuvanted vaccine reveals a better immunogenicity.
KeywordsAntibody response Influenza MF59 Vaccine
Unable to display preview. Download preview PDF.
- 2.De Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus ADME (2003) Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 115:63–73Google Scholar
- 5.Beyer WEP, Palache AM, Osterhaus ADME (1998) Comparison of serology and reactogenicity between influenza subunit vaccine and whole virus or split virus: a review and meta-analysis of the literature. Clin Drug Invest 15:1–12Google Scholar
- 8.Nicholson KG, Colegate AE, Podda A, Stephenson I, Wood J, Ypma E, Zambon MC (2001) Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 357:1937–1943PubMedCrossRefGoogle Scholar